# Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With Psoriasis.

> **NCT00407342** · NA · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 14 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Alefacept (drug)
- **PROCEDURE:** Narrowband UVB phototherapy

## Key facts

- **NCT ID:** NCT00407342
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2004-06
- **Final completion:** 2004-09
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2009-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00407342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00407342, "Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With Psoriasis.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00407342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*